Back to 
BARCLAYS PLC
BARCLAYS PLCPRPRAX
Showing 0 of 6 quarters
Position history for BARCLAYS PLC's holdings in PRAXIS PRECISION MEDICINES I
No. Barclays exited its PRAX (Praxis Precision Medicines) position in Q2 2023. Its Q1 2023 13F listed 24,167 shares worth $19,552. Barclays first reported PRAX in Q1 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.